| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A new threat to obesity: vanity sizing
|
Pérez-Martínez, Pablo
|
|
|
13 |
4 |
p. 276-277
|
article
|
| 2 |
A step towards more physiological glucocorticoid dosing in congenital adrenal hyperplasia
|
Reincke, Martin
|
|
|
13 |
4 |
p. 272-274
|
article
|
| 3 |
Bodyweight loss and remission of type 2 diabetes
|
Birkenfeld, Andreas L
|
|
|
13 |
4 |
p. 265-267
|
article
|
| 4 |
Correction to Lancet Diabetes Endocrinol 2025; 13: 47–56
|
|
|
|
13 |
4 |
p. e7
|
article
|
| 5 |
Correction to Lancet Diabetes Endocrinol 2025; 13: 175–76
|
|
|
|
13 |
4 |
p. e7
|
article
|
| 6 |
Correction to Lancet Diabetes Endocrinol 2024; 12: 523–34
|
|
|
|
13 |
4 |
p. e7
|
article
|
| 7 |
Correction to Lancet Diabetes Endocrinol 2024; 12: e2–11
|
|
|
|
13 |
4 |
p. e7
|
article
|
| 8 |
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
|
Aggarwal, Rahul
|
|
|
13 |
4 |
p. 321-332
|
article
|
| 9 |
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
|
Sattar, Naveed
|
|
|
13 |
4 |
p. 347-354
|
article
|
| 10 |
Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials
|
Kanbour, Sarah
|
|
|
13 |
4 |
p. 294-306
|
article
|
| 11 |
Kidney disease at the forefront of the global health agenda
|
The Lancet Diabetes & Endocrinology,
|
|
|
13 |
4 |
p. 263
|
article
|
| 12 |
Long-term outcomes and challenges of islet transplantation in type 1 diabetes
|
Chetboun, Mikael
|
|
|
13 |
4 |
p. 264-265
|
article
|
| 13 |
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy
|
Catarinella, Davide
|
|
|
13 |
4 |
p. 279-293
|
article
|
| 14 |
Sodium–glucose co-transporter inhibitors—who would have guessed?
|
Norhammar, Anna
|
|
|
13 |
4 |
p. 268-270
|
article
|
| 15 |
The need for a type 1 diabetes scorecard
|
de Beaufort, Carine
|
|
|
13 |
4 |
p. 277-278
|
article
|
| 16 |
The promise and pitfalls of “Make America Healthy Again”
|
Tallie, Lindsey Smith
|
|
|
13 |
4 |
p. 274-275
|
article
|
| 17 |
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
|
Abaandou, Laura
|
|
|
13 |
4 |
p. 333-346
|
article
|
| 18 |
Vitamin D and acute respiratory infections: a definitive answer?
|
Gallagher, Chris
|
|
|
13 |
4 |
p. 267-268
|
article
|
| 19 |
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data
|
Jolliffe, David A
|
|
|
13 |
4 |
p. 307-320
|
article
|
| 20 |
What does renal failure teach us about our National Health System?
|
Avogaro, Angelo
|
|
|
13 |
4 |
p. 276
|
article
|
| 21 |
When glucose time in range is not tight, is it lax? Considering new terminology for CGM targets
|
Wang, Ray
|
|
|
13 |
4 |
p. 270-272
|
article
|
Journal description